SCHEMBL282605

SCHEMBL282605

CCCCC(CO)OCC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
MAPT P10636 2/20 0.39
MAPK1 P28482 1/20 0.39
LMNA P02545 2/20 0.39
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
PRKCA P17252 2/20 0.34
PRKCD Q05655 2/20 0.34
PRKCE Q02156 1/20 0.34
PRKCQ Q04759 1/20 0.34
CYP2D6 P10635 2/20 0.33
THRB P10828 1/20 0.33
SPHK1 Q9NYA1 1/20 0.33
GMNN O75496 1/20 0.33
POLB P06746 1/20 0.33
THPO P40225 1/20 0.33
MTOR P42345 1/20 0.33
BLM P54132 1/20 0.33
KDM4E B2RXH2 1/20 0.33
TP53 P04637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5832205 0.93 LMNA (0.48) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL28803871 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL28253004 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL10800419 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL9805659 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL10796538 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL5857227 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL27817187 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL27503911 0.91 LMNA (0.52) ALDH1A1MAPTMAPK1LMNACNR1
SCHEMBL8679166 0.86 ALDH1A1 (0.33) ALDH1A1MAPTMAPK1LMNACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260103653-A1 OCTANE-ENHANCING COMPOSITION, METHOD OF USE THEREOF, AND KIT CONTAINING THE SAME ILLINOIS TOOL WORKS INC. (US) 2026-04-16 US claimed
EP-4726014-A1 OCTANE-ENHANCING COMPOSITION, METHOD OF USE THEREOF, AND KIT CONTAINING THE SAME Illinois Tool Works Inc. (US) 2026-04-15 EP claimed
US-20240051264-A1 LAMINATED IRON CORE AND MANUFACTURING METHOD THEREOF POSCO CO., LTD (KR) 2024-02-15 US claimed
EP-4266560-A1 LAMINATED IRON CORE AND MANUFACTURING METHOD THEREOF POSCO Co., Ltd (KR) 2023-10-25 EP claimed
CN-116918224-A Laminated iron core and method for manufacturing the same 浦项股份有限公司 2023-10-20 CN claimed
WO-2022139358-A1 LAMINATED IRON CORE AND MANUFACTURING METHOD THEREOF 주식회사 포스코 2022-06-30 WO claimed
EP-0300738-A2 Process for esters EXXON CHEMICAL PATENTS INC. (US) 1989-01-25 EP claimed
US-12479960-B2 Triazine ring-containing polymer and film forming composition containing same NISSAN CHEMICAL CORPORATION (JP) 2025-11-25 US disclosed
US-20250215256-A1 POLYMER FILM-FORMING COMPOSITION AND SELECTIVE POLYMER FILM-FORMING METHOD NISSAN CHEMICAL CORPORATION (JP) 2025-07-03 US disclosed
US-20250171662-A1 THERMOFORMED SHEET 3M INNOVATIVE PROPERTIES COMPANY (US) 2025-05-29 US disclosed
WO-2025100536-A1 COPOLYMER, NONLINEAR OPTICAL MATERIAL, AND ELECTRO-OPTIC ELEMENT 大阪有機化学工業株式会社 2025-05-15 WO disclosed
US-20250154340-A1 COMPOSITION CONTAINING NONLINEAR OPTICALLY ACTIVE COPOLYMER NISSAN CHEMICAL CORPORATION (JP) 2025-05-15 US disclosed
CN-114599704-B Triazine ring-containing polymer and film-forming composition containing same 日产化学株式会社 2025-02-14 CN disclosed
EP-0151446-A2 Liquid crystal phase MERCK PATENT GmbH (DE) 1985-08-14 EP disclosed
US-4323453-A EPOXY RESIN CURED WITH AN IMIDAZOLE, HOLLOW FIBERS MONSANTO COMPANY (US) 1982-04-06 US disclosed
US-4318939-A GELATION INHIBITION, AN ORGANO TITATNIUM CURING CATALYST WESTERN ELECTRIC CO., INCORPORATED (US) 1982-03-09 US disclosed
US-4130753-A Control systems PACTROL CONTROLS LIMITED (GB) 1978-12-19 US disclosed
US-4091052-A BUTADIENE, ACRYLIC ESTER, FREE RADICAL CATALYSTS NIPPON OIL COMPANY LIMITED (JA) 1978-05-23 US disclosed
US-4040977-A HALOACETAMIDE OR THIOCYANOACETAMIDE-ALCOHOL-FORMALDEHYDE CONDENSATES STERLING DRUG INC. (US) 1977-08-09 US disclosed
US-3949220-A Method for detecting and locating sand producing zones in friable, unconsolidated sandstone formations of subterranean formations CONTINENTAL OIL COMPANY (US) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260103653-A1 OCTANE-ENHANCING COMPOSITION, METHOD OF USE THEREOF, AND KIT CONTAINING THE SAME HMOX2, BHMT2, NONO ALDH1A1 1584/4885MAPT 1917/4885MAPK1 3042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.